Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. - Wikidata - wikimedia - TriplyDB

Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.

Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.

http://www.wikidata.org/entity/Q39746326

about

The Cryptococcus neoformans capsule: a sword and a shield.Virulence-Associated Enzymes of Cryptococcus neoformans Enzymatic modifications of exopolysaccharides enhance bacterial persistence Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.Cas3p belongs to a seven-member family of capsule structure designer proteins.How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo.Cryptococcus neoformans capsule structure evolution in vitro and during murine infection Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan.Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier A xylosylphosphotransferase of Cryptococcus neoformans acts in protein O-glycan synthesis.Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen Multiple Disguises for the Same Party: The Concepts of Morphogenesis and Phenotypic Variations in Cryptococcus neoformans Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.Isolation and purification of antigenic components of Cryptococcus Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans In Vitro Analysis of Metabolites Secreted during Infection of Lung Epithelial Cells by Cryptococcus neoformans Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure A defect in ATP-citrate lyase links acetyl-CoA production, virulence factor elaboration and virulence in Cryptococcus neoformans.Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides Synthesis of cell envelope glycoproteins of Cryptococcus laurentii.Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans The capsule of the fungal pathogen Cryptococcus neoformans.Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsule Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies.Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter.The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding.Unraveling the biology of a fungal meningitis pathogen using chemical genetics.Characterization of the antigenicity of Cpl1, a surface protein of Cryptococcus neoformans var. neoformans.Role for chitin and chitooligomers in the capsular architecture of Cryptococcus neoformans.UDP-glucose dehydrogenase plays multiple roles in the biology of the pathogenic fungus Cryptococcus neoformans.Distribution of the O-acetyl groups and β-galactofuranose units in galactoxylomannans of the opportunistic fungus Cryptococcus neoformans.Regulated release of cryptococcal polysaccharide drives virulence and suppresses immune infiltration into the central nervous system.UDP-Glucuronic Acid Transport Is Required for Virulence of Cryptococcus neoformans.Xylose donor transport is critical for fungal virulence.An alpha-1,3-mannosyltransferase of Cryptococcus neoformans.

P2860

Q24619875-930004B2-756F-4AE9-B6EB-F88DDE33F34A Q26785005-4579A67D-A32F-4C34-874E-7D35FD50DE24 Q27009503-79CE7512-26B7-4990-8B7B-ABB99935D493 Q30479935-8399AF4D-C2C5-47CF-A89F-5F786DDBA4CC Q33263249-E34C9C89-2D09-4325-B7C6-67C7B5029781 Q33560210-0D2073DB-C63C-4D94-81FD-8E4F7829696B Q33894565-FBED1C7A-D407-409E-B58A-B7230A0E7337 Q33939999-0EA6B656-C4CB-4350-B68F-EF94BFAF26BD Q34146274-FB98F95A-73B9-49DE-A935-C6DBB6C7D1F0 Q34680995-217624F1-16F9-4289-B4C0-B288A39AA962 Q34907746-42B9C076-8371-49B4-9BD4-5FBB29DC8326 Q35083658-A42EA079-8956-4489-8DE1-5ED3FB877CA5 Q35128286-2DE3E0EB-DB34-4041-81AC-3BB65A6F6E73 Q35138768-114CDA4F-7B6C-4D47-8BF8-8A934D7C5C24 Q35197055-93EBF824-37DB-419D-A8DD-8DDFA7CCA21F Q35641032-6F41CAA6-A14B-48D1-8464-BFABF645CC74 Q35813386-74FB8242-2BC3-4F4A-8349-F65CBAF99D32 Q35923662-0E15DFC0-9C55-4C54-848C-F11A1A6B0C0B Q35982390-CFA21343-0EB7-4727-B0EF-285A6495B834 Q36244332-2AFFBB8C-C494-465B-A0AE-5E4EA07BEC00 Q36431950-B0D42CAF-648A-4B23-8F34-6A6A09C730D6 Q36472903-D24C5126-7588-496C-A236-3DE644C8413D Q36662728-8807DC57-AEB8-4D4D-A00F-FF180E3E4425 Q36742785-2EA0D2EA-9876-458B-8EE8-5A67A112F604 Q37033075-6CFB4CFC-8D57-4FD0-9C1E-CA04E205F912 Q37337879-6B7C9F6E-0913-4B3D-A506-112A9F46D68B Q37459771-F34AF55C-91BD-4544-A7B7-C3185E325ABA Q38363105-2723093E-5FF1-42F8-8622-C4E061F0E1B5 Q39693119-26BE4A7E-1DF1-4BCC-8FD3-1A1F3A013BE9 Q40339381-F3535E74-056A-42BD-B918-956E7211C837 Q41652452-56E8F832-0199-442F-9143-A159060F77DE Q41724513-C4C54B3B-5901-4EFD-86CA-0D54B5EF6068 Q42017970-1B091551-3E04-45ED-B60A-EC7A669B8713 Q45071193-146DCAEE-E3B6-457E-BA1A-0F1E65E580EC Q46444722-93DBD72C-9DD9-4144-A2BB-776BB419C43D Q47370987-8780B9DD-E5B3-4E31-9C87-216134549691 Q47830888-DC5EA593-38A4-4AAC-8950-E9F30A4B1DE4 Q48218058-D3536A85-F0BD-44E1-9C02-1DB25F77C10A Q48227152-184B160D-32B3-463E-A2F5-9BB1AD484CB6

P2860

Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.

http://www.wikidata.org/entity/Q39746326

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Antigenic and biological chara ...... lation or xylosyl side chains.

@en

Antigenic and biological chara ...... lation or xylosyl side chains.

@nl

type

label

Antigenic and biological chara ...... lation or xylosyl side chains.

@en

Antigenic and biological chara ...... lation or xylosyl side chains.

@nl

prefLabel

Antigenic and biological chara ...... lation or xylosyl side chains.

@en

Antigenic and biological chara ...... lation or xylosyl side chains.

@nl

P1433

Q39746326-75E87A8A-DC16-47C7-8E02-D8578E425532

P1476

Q39746326-BB75627C-09EF-47A1-81C6-0A9A6776063C

P2093

Q39746326-16B583DB-2E02-4E76-BDC1-2877DCB969D8

Q39746326-1BA4C6C5-D775-4A92-B7A0-7CB6359CC970

Q39746326-25AB194A-27AD-465C-A122-1141B9F6FBF6

Q39746326-9CB66023-E929-4C50-831D-B1A5E4D556A5

P2860

Q39746326-05DE0296-F3E8-4A67-8898-6D5DD46B6BCB

Q39746326-06948A7B-9177-4310-9985-0601B7091741

Q39746326-08B321D9-C436-487C-8D7F-AC08D954B19F

Q39746326-1D87D98C-2E45-419D-BBCB-5A509A1081A9

Q39746326-27B2B0C5-2BBF-4667-907C-4036D36AD41A

Q39746326-2B2F96CD-2BC9-4E70-89EC-14E72E0FE860

Q39746326-2C115B84-6EBC-4FBA-B30E-F946425A8FE6

Q39746326-31DEBF55-8ED9-4B40-A381-AD65445A5A9C

Q39746326-352D1D8D-07EE-41B2-A2F7-6C859DA257C0

Q39746326-3F5FD4FB-82EB-4A17-8C39-DDF93DEE055E

P304

Q39746326-7985523A-79A0-4EEC-BB6E-FC75D594FC41

P31

Q39746326-1503CAAE-B874-4C42-A5CA-AF2E9FE3ED50

P356

Q39746326-7B7382EA-5B7F-480B-A53A-5BA19C909ED3

P407

Q39746326-5E2CAD2A-E125-43C0-A24D-004DC9B445F3

P433

Q39746326-EA0F5563-FE67-4083-9F33-56D9781E6B18

P478

Q39746326-457CF0B2-F0D5-46F6-8239-AC0B309B4076

P50

Q39746326-59522C2D-B67E-4777-A3CA-D1DC6AAEBC53

Q39746326-bc759a66-47ac-d501-a552-f5d552286cf3

P577

Q39746326-F5673DA0-E333-4946-BC58-1BAA39540040

P698

Q39746326-8DC2FDF7-C1E7-48E3-A291-CD65412C63E8

P932

Q39746326-E6EF3986-A811-41D7-AA4A-0026D0A7C151

P356

IAI.71.5.2868-2875.2003

P1433

Infection and Immunity

P1476

Antigenic and biological chara ...... lation or xylosyl side chains.

@en

P2093

Françoise Dromer

http://www.w3.org/2001/XMLSchema#string

Marcellene A Gates

http://www.w3.org/2001/XMLSchema#string

Peter Thorkildson

http://www.w3.org/2001/XMLSchema#string

Stuart M Levitz

http://www.w3.org/2001/XMLSchema#string

P2860

Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.

Functional cloning and characterization of a UDP- glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis.

Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network

Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity

Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness

Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique

Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide

Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.

Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.

Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes

P304

2868-2875

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.71.5.2868-2875.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Thomas R. Kozel

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12704160

http://www.w3.org/2001/XMLSchema#string

P932

153297

http://www.w3.org/2001/XMLSchema#string